AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Eriglim M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Simpatico Healthcare

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Eriglim M 1mg/500mg Tablet SR

Diabetol Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabetol Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, increasing the risk of complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. Remember, this medication is one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Commonly reported side effects include hypoglycemia (low blood sugar). Learn to identify hypoglycemic symptoms like sweating, dizziness, headache, and tremors, and know how to treat them promptly. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating women should consult their doctor prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended by your physician.

Uses of Eriglim M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Eriglim M 1mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. The Eriglim M 1mg/500mg sustained-release tablet should be taken with a meal.

Common Side effects of Eriglim M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Eriglim M 1mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Eriglim M 1mg/500mg sustained-release tablets should be administered with a meal.

How Eriglim M 1mg/500mg Tablet SR works:

Eriglim M 1mg/500mg Extended-Release Tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Eriglim M 1mg/500mg SR tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Eriglim M 1mg/500mg SR tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against potential hazards prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Eriglim M 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Eriglim M 1mg/500mg SR tablets; dosage modification may be necessary. A physician's consultation is advised. Eriglim M 1mg/500mg SR tablets are contraindicated in individuals with severely compromised kidney function. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Eriglim M 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, initiating treatment with a low dose of Eriglim M 1mg/500mg Tablet SR is typical; however, its use is contraindicated in patients exhibiting severe hepatic dysfunction.

What if you forget to take Eriglim M 1mg/500mg Tablet SR :

Should you forget to take a dose of Eriglim M 1mg/500mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Eriglim M 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Eriglim M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Eriglim M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Eriglim M 1mg/500mg Tablet SR and seek immediate medical attention.
Eriglim M 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Eriglim M 1mg/500mg Tablet SR may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Eriglim M 1mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Eriglim M 1mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with skipped meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Eriglim M 1mg/500mg SR tablets with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Eriglim M 1mg/500mg Table...
60
MRP 70
14% off